Progranulin Protein

Progranulin Protein

<div class="infobox infobox-protein">

| Property | Value |
|----------|-------|
| Protein Name | Progranulin |
| Gene | GRN |
| UniProt ID | P28799 |
| Molecular Weight | ~90 kDa (secreted); 68 kDa (granulin domain) |
| Subcellular Localization | Secreted; also localizes to lysosomes |
| Protein Family | Granulin family |
| Tissue Expression | Highest in brain (neurons, microglia), immune cells |

</div>

Pathway Diagram

Progranulin Protein

<div class="infobox infobox-protein">

| Property | Value |
|----------|-------|
| Protein Name | Progranulin |
| Gene | GRN |
| UniProt ID | P28799 |
| Molecular Weight | ~90 kDa (secreted); 68 kDa (granulin domain) |
| Subcellular Localization | Secreted; also localizes to lysosomes |
| Protein Family | Granulin family |
| Tissue Expression | Highest in brain (neurons, microglia), immune cells |

</div>

Pathway Diagram

Overview

Progranulin is a secreted glycoprotein encoded by the [GRN](/genes/grn) gene that functions as a multifunctional growth factor and regulator of lysosomal function[@baker2006]. It plays critical roles in neuronal survival, wound healing, inflammation, and protein homeostasis. Heterozygous loss-of-function mutations in GRN cause frontotemporal dementia (FTD), making it one of the most common genetic causes of this disorder. The protein is also implicated in Alzheimer's disease, Parkinson's disease, and lysosomal storage disorders[@hebreve2022].

Progranulin is unique among neurodegenerative disease proteins in that it functions as a secreted signaling molecule with both protective and pathological roles depending on context. The protein contains multiple granulin domains that can be proteolytically cleaved to generate small granulin peptides with distinct biological activities.

Structure and Processing

Domain Architecture

Progranulin contains several distinct structural features[@hebreve2022]:

The full-length protein (~90 kDa) can be cleaved by various proteases to generate granulin peptides (6-25 kDa), including:

• Granulin A: N-terminal granulin
• Granulin B: Central region
• Paragranulin: Alternative cleavage product

Proteolytic Processing

Progranulin processing is regulated by several proteases:

| Protease | Cleavage Site | Functional Impact |
|----------|---------------|-------------------|
| Elastase | Multiple sites | Generates granulin peptides |
| MMP-9 | After granulin repeats | Produces active fragments |
| ADAMTS-4 | N-terminal | Regulates signaling |
| Cathepsin D | Lysosomal | Generates intracellular granulin |

The balance between full-length progranulin and granulin peptides determines downstream functions, as these species have distinct receptor interactions and biological activities.

Normal Biological Function

Neuronal Survival and Development

Progranulin supports neuronal health through multiple mechanisms[@gass2024]:

Lysosomal Function

A critical function of progranulin is its role in lysosomal biology[@gass2024]:

Progranulin deficiency leads to enlarged lysosomes with impaired cathepsin activity, accumulating lipofuscin, and disrupted autophagy flux.

Inflammation and Immunity

Progranulin modulates immune responses:

Tissue Repair

Beyond the nervous system, progranulin functions in:

• Angiogenesis and blood vessel formation
• Bone metabolism and fracture healing
• Muscle regeneration after injury

Role in Neurodegeneration

Frontotemporal Dementia (FTD)

GRN mutations are a major cause of familial FTD[@baker2006]:

Genetic Basis:

• Inheritance: Autosomal dominant, haploinsufficiency
• Mechanism: Loss-of-function mutations reduce progranulin levels by ~50%
• Penetrance: Nearly complete by age 80
• Age of onset: Typically 45-65 years

Clinical Phenotype:

• Behavioral variant FTD (most common)
• Primary progressive aphasia
• Movement disorders (PSP-like)

Alzheimer's Disease

Progranulin has complex relationships with AD pathogenesis:

Parkinson's Disease

Emerging evidence links progranulin to PD:

Therapeutic Implications

Current Strategies

Several approaches target progranulin pathways[@gass2024]:

| Strategy | Approach | Status |
|----------|----------|--------|
| Protein replacement | Recombinant progranulin | Preclinical |
| Gene therapy | AAV-GRN | Phase 1/2 trials |
| Small molecules | Increase GRN expression | Discovery |
| Protease inhibitors | Block granulin generation | Research |

Challenges

Related Therapies

• [Aducanumab](/therapeutics/aducanumab) — Amyloid-targeting AD therapy
• [Lecanemab](/therapeutics/lecanemab) — Amyloid-targeting AD therapy
• [Antisense oligonucleotides](/treatments/antisense-oligonucleotide-therapy) — Gene-specific approach

Key Publications

Cross-References

• [GRN Gene](/genes/grn) — Gene encoding progranulin
• [Frontotemporal Dementia](/diseases/frontotemporal-dementia) — Primary disease
• [Alzheimer's Disease](/diseases/alzheimers-disease) — Related disease
• [Parkinson's Disease](/diseases/parkinsons-disease) — Related disease
• [TDP-43 Proteinopathy](/mechanisms/tdp-43-proteinopathy) — Associated pathology
• [Lysosomal Dysfunction](/mechanisms/lysosomal-dysfunction) — Pathogenic mechanism

See Also

• [Protein Aggregation](/mechanisms/protein-aggregation-mechanisms)
• [Neuroinflammation](/mechanisms/neuroinflammation-mechanisms)
• [Aging and Neurodegeneration](/topics/aging-and-neurodegeneration)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving Progranulin Protein discovered through SciDEX knowledge graph analysis: